Use of cytomegalovirus antigenemia as a marker for preemptive treatment.
Guirado L, Herreros MA, Muñoz JM, Rabella N, Facundo C, Agraz I, Díaz M, Diaz JM, Durán F, Solà R.
Guirado L, et al. Among authors: facundo c.
Transplant Proc. 2002 Feb;34(1):67-8. doi: 10.1016/s0041-1345(01)02668-9.
Transplant Proc. 2002.
PMID: 11959188
No abstract available.